Method development for pharmaceutics: some solutions for tuning selectivity in reversed phase and hydrophilic interaction liquid chromatography

Journal of Pharmaceutical and Biomedical Analysis
Josephine RutaDavy Guillarme

Abstract

In LC method development, the choice of suitable experimental conditions is often challenging for the analyst because of the huge diversity of stationary phases, mobile phase pH and organic modifiers, that could significantly alter the selectivity. The influence of these parameters on selectivity was experimentally tested in both RPLC and HILIC conditions for the analysis of 45 pharmaceutical compounds covering a wide range of physico-chemical properties. Principal component analysis (PCA) models were built to assess the resulting multivariate dataset. The complementarity between RPLC and HILIC was clearly demonstrated. The importance of mobile phase pH as one of the main experimental factors to be considered was confirmed. The RPLC and HILIC methods were thus employed for the analysis of a drug cocktail containing two substrates and their numerous desmethylated metabolites. All the compounds were finally resolved in both modes, with a very distinct elution order. In addition, the possibility to combine columns of different selectivity was highlighted using a column coupler set-up and found to be extremely promising. The same type of experiments was also carried out for the impurity profiling of an antihistaminic drug. In this ...Continue Reading

References

Feb 7, 1997·Journal of Chromatography. B, Biomedical Sciences and Applications·L R Snyder
Jan 9, 1999·Medical Hypotheses·J S Markowitz, K S Patrick
Jan 12, 2005·Journal of Chromatography. a·K Le MapihanA Jardy
Oct 1, 2005·Analytical Chemistry·Martin GilarJohn C Gebler
Apr 18, 2006·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·K R Allen
Sep 15, 2006·Journal of Separation Science·Petrus Hemström, Knut Irgum
Oct 19, 2006·Current Opinion in Biotechnology·Moo-Yeal Lee, Jonathan S Dordick
Feb 3, 2007·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Davy GuillarmeJean-Luc Veuthey
Aug 21, 2007·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Davy GuillarmeJean-Luc Veuthey
Mar 28, 2008·Southern Medical Journal·Roy R Reeves, Sera K Cox
Feb 16, 2010·Journal of Separation Science·Wenying JianNaidong Weng
Feb 27, 2010·Journal of Separation Science·Konstantina SpagouGeorgios Theodoridis
Jan 5, 2011·Analytical Chemistry·Deirdre CabooterGert Desmet
Mar 18, 2011·Journal of Chromatography. a·Xiaoping Li, Peter W Carr
May 1, 2010·Expert Opinion on Drug Discovery·Raul NicoliDavy Guillarme

❮ Previous
Next ❯

Citations

Dec 23, 2015·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·René Holm, David P Elder
Oct 14, 2018·Biomedical Chromatography : BMC·Aimin Tan, John C Fanaras

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here